Jack E Belen, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 28080 Grand River Ave Ste 306n, Farmington Hills, MI 48336 Phone: 947-521-8968 Fax: 248-471-8061 |
Muhammad Umair Alam, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 32255 Northwestern Hwy Ste 50, Farmington Hills, MI 48334 Phone: 248-419-3505 Fax: 248-419-3506 |
Prabhat K Sinha, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 29275 W 10 Mile Rd, Farmington Hills, MI 48336 Phone: 248-350-2722 Fax: 248-350-0154 |
Sanford Howard Sklar, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 29275 W 10 Mile Rd, Farmington Hills, MI 48336 Phone: 248-350-2722 Fax: 248-350-0154 |
Steven B Rubin, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 32255 Northwestern Hwy, Suite 130, Farmington Hills, MI 48334 Phone: 248-723-5880 Fax: 248-723-5889 |
Dr. Bertram B Rabinowitz, DO Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 28080 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-471-8982 Fax: 248-478-7179 |
Dr. Muhammad Ali Ehtesham, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 29275 W 10 Mile Rd, Farmington Hills, MI 48336 Phone: 248-350-2722 Fax: 248-350-0154 |
Dr. Harvey W Organek, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 29275 W 10 Mile Rd, Farmington Hills, MI 48336 Phone: 248-350-2722 Fax: 248-350-0154 |
News Archive
The National Cancer Institute has awarded a five-year, $13.6 million grant to the University of North Carolina at Chapel Hill's Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) based at the UNC Lineberger Comprehensive Cancer Center, for research to improve the diagnosis and treatment of cancer through applying/using advances in nanotechnology.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced a strategic collaboration with Brigham and Women's Hospital in Boston, to advance basic and clinical research in multiple sclerosis (MS), with the goal of generating new and innovative discoveries that advance treatment for people living with this condition. The multi-faceted agreement will run for up to 5 years, with the potential to renew the alliance thereafter. Both parties decided not to disclose financial details.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.
For many people with gastroesophageal reflux disease or GERD, acid reflux drugs are the answer to their woes, curbing the chronic heartburn and regurgitation of food or sour liquid characteristic of the disorder. But when it comes to Barrett's esophagus, a condition commonly found in people with GERD, acid control may be less important than beating back another bodily fluid - bile.
The University of Chichester has been chosen to lead research into a developing a sports-specific classification system for blind football.
› Verified 5 days ago